S V Chiplunkar
 
 
  1. Understanding the immunobiology of γδ T cells with reference to anti–tumor immunity
  2. Mechanism of immune dysfunction in patients –Role of CD3–zeta chain and Cox
  3. Clonality of TCR and Ig genes in Leukemias and Lymphomas
  4. Crosstalk of NKT cells and Regulatory T cells
  5. Biomarkers for cancer diagnosis and prognosis
  6. Immunotherapy of cancer
 
Research Overview
The focus of my group is on understanding the immune scenario and reasons for immune dysfunctions in patients with cancer. The group is also interested in studying the role of hematopoietic and mesenchymal stem cells for management of hematological neoplasms, tissue regeneration and repair.
Shubhada Chiplunkar PhD
Director, ACTREC & Principal Investigator
PhD Mumbai University (1983)
Post-doctoral Research Max Planck Institute Fur Immunologie, Freiburg, Germany (1984-86)
 
Current interests:
 
 
 
Home Research Projects Laboratory Members    Recent Publications Contacts Links
 
Home Research Projects Laboratory Members    Recent Publications Contacts Links